Article 3 Amendment of Schedule 3A to the principal Order

for the entry for “Erythromycin”, in column 2, after “External Use” insert “or oral”;

for the entry “Fusidic acid”, in column 2 for “Opthalmic Use” substitute “External Use”;

for the entry “Hycosine butylbromide”, in column 2, after “parenteral” insert “or transdermal”;

for the entry “Hycosine hydrobromide”, in column 2, for “Oral, parenteral or transdermal administration in palliative care” substitute “Oral or parenteral administration in palliative care”;

for the entry “Metronidazole”, in column 2 for “External use or oral” substitute “External use, oral or rectal”;

for the entry “Prednisolone sodium phosphate”, in column 2, after “Aural” insert “or oral”;

in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 below, and in column 2 insert, against those entries, the corresponding entries in column 2 below—